Payment overview · 2025
General Payments
$19.57
1 reported records · 1 companies
Healthcare provider profile · identity verified
Philip W Lee, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · HIGHLAND, CA · NPI 1255387320
Verified facts
What the public records show
CMS Open Payments records show Philip W Lee, M.D. received $19.57 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $19.57 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.57 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $19.57 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1076 | 329 |
| Metoprolol Succinate | Metoprolol Succinate | 655 | 186 |
| Amlodipine Besylate | Amlodipine Besylate | 584 | 168 |
| Losartan Potassium | Losartan Potassium | 501 | 150 |
| Levothyroxine Sodium | Levothyroxine Sodium | 414 | 121 |
| Metformin Hcl | Metformin Hcl | 348 | 102 |
| Pantoprazole Sodium | Pantoprazole Sodium | 323 | 97 |
| Lisinopril | Lisinopril | 302 | 90 |
| Tamsulosin Hcl | Tamsulosin Hcl | 294 | 92 |
| Gabapentin | Gabapentin | 265 | 87 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 261 | 77 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 258 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 253 | 90 |
| Ozempic | Semaglutide | 248 | 39 |
| Omeprazole | Omeprazole | 243 | 62 |
| Eliquis | Apixaban | 232 | 55 |
| Furosemide | Furosemide | 229 | 73 |
| Baclofen | Baclofen | 220 | 62 |
| Trazodone Hcl | Trazodone Hcl | 193 | 58 |
| Finasteride | Finasteride | 190 | 56 |
| Jardiance | Empagliflozin | 185 | 63 |
| Metformin Hcl Er | Metformin Hcl | 181 | 56 |
| Prednisone | Prednisone | 180 | 140 |
| Ibuprofen | Ibuprofen | 155 | 43 |
| Glimepiride | Glimepiride | 144 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 135 | 38 |
| Nifedipine Er | Nifedipine | 135 | 45 |
| Tramadol Hcl | Tramadol Hcl | 134 | 26 |
| Simvastatin | Simvastatin | 131 | 36 |
| Famotidine | Famotidine | 129 | 47 |
| Hydralazine Hcl | Hydralazine Hcl | 128 | 36 |
| Carvedilol | Carvedilol | 114 | 34 |
| Sildenafil Citrate | Sildenafil Citrate | 114 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 113 | 31 |
| Potassium Chloride | Potassium Chloride | 112 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 108 | 38 |
| Ibandronate Sodium | Ibandronate Sodium | 103 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 102 | 37 |
| Alendronate Sodium | Alendronate Sodium | 100 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 88 | 32 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 85 | 30 |
| Diclofenac Sodium | Diclofenac Sodium | 84 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 83 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 83 | 38 |
| Sertraline Hcl | Sertraline Hcl | 81 | 21 |
| Xarelto | Rivaroxaban | 80 | 15 |
| Alprazolam | Alprazolam | 79 | 17 |
| Clonidine Hcl | Clonidine Hcl | 79 | 31 |
| Allopurinol | Allopurinol | 78 | 25 |
| Rybelsus | Semaglutide | 75 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 74 | 60 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 72 | 63 |
| Benazepril Hcl | Benazepril Hcl | 70 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 70 | 19 |
| Livalo | Pitavastatin Calcium | 69 | 12 |
| Meloxicam | Meloxicam | 69 | 19 |
| Clobetasol Propionate | Clobetasol Propionate | 61 | 33 |
| Azithromycin | Azithromycin | 60 | 50 |
| Donepezil Hcl | Donepezil Hcl | 59 | 11 |
| Januvia | Sitagliptin Phosphate | 59 | 17 |
| Lovastatin | Lovastatin | 57 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 54 | 16 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 50 | 17 |
| Memantine Hcl | Memantine Hcl | 49 | 12 |
| Levofloxacin | Levofloxacin | 48 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 48 | 19 |
| Valacyclovir | Valacyclovir Hcl | 48 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | 14 |
| Meclizine Hcl | Meclizine Hcl | 45 | 12 |
| Vascepa | Icosapent Ethyl | 45 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 43 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 41 | suppressed |
| Naproxen | Naproxen | 38 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 38 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 38 | 12 |
| Atenolol | Atenolol | 35 | suppressed |
| Ezetimibe | Ezetimibe | 34 | 15 |
| Linzess | Linaclotide | 34 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 33 | suppressed |
| Lidocaine | Lidocaine | 33 | suppressed |
| Spironolactone | Spironolactone | 33 | suppressed |
| Ketoconazole | Ketoconazole | 32 | 13 |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Valsartan | Valsartan | 32 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 31 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 30 | suppressed |
| Ondansetron Odt | Ondansetron | 30 | 13 |
| Breyna | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Cefdinir | Cefdinir | 29 | 21 |
| Glipizide | Glipizide | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | 13 |
| Montelukast Sodium | Montelukast Sodium | 28 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 27 | 11 |
| Lorazepam | Lorazepam | 27 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 26 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 24 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Bupropion Xl | Bupropion Hcl | 23 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Methocarbamol | Methocarbamol | 23 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 23 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Trulicity | Dulaglutide | 22 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Levemir Flexpen | Insulin Detemir | 19 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Cephalexin | Cephalexin | 18 | 17 |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Invokana | Canagliflozin | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Klor-Con 8 | Potassium Chloride | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Fluconazole | Fluconazole | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | 12 |
| Nystatin | Nystatin | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 13 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Ubrelvy | Ubrogepant | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Nexium | Esomeprazole Magnesium | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.57 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error